{"id":26742,"date":"2023-01-30T13:53:57","date_gmt":"2023-01-30T13:53:57","guid":{"rendered":"https:\/\/www.neuraxpharm.com\/ch-fr\/?page_id=26742"},"modified":"2023-03-27T09:45:17","modified_gmt":"2023-03-27T09:45:17","slug":"miguel-barrero-2","status":"publish","type":"page","link":"https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous\/comite-executif\/miguel-barrero-2","title":{"rendered":"MIGUEL BARRERO"},"content":{"rendered":"\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
\n\t\t\t<\/i>\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

https:\/\/www.linkedin.com\/in\/mbarrero\/<\/a><\/p>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t

\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t
\n\t\t
\n\t\t
Neuraxpharm<\/a><\/div>\n\t\t<\/div>\n\t\t<\/div>\n\t\t<\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Miguel Barrero<\/h1>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Miguel Barrero Dur\u00e1n est Head of Business Development & Innovation et a rejoint Neuraxpharm en 2015 o\u00f9 il a cr\u00e9\u00e9 et d\u00e9velopp\u00e9 les d\u00e9partements du d\u00e9veloppement commercial et des licences, de la gestion des alliances et, r\u00e9cemment, du portefeuille de produits. Miguel dirige \u00e9galement le d\u00e9partement de propri\u00e9t\u00e9 intellectuelle.<\/p>

Il a plus de 22 ans d’exp\u00e9rience dans l’industrie pharmaceutique, \u00e0 diff\u00e9rents postes et dans diff\u00e9rentes entreprises. Il a commenc\u00e9 sa carri\u00e8re professionnelle en 2000 chez Almirall, puis a rejoint Merck Serono en 2005 et Esteve en 2008, o\u00f9 il a occup\u00e9 des postes \u00e0 responsabilit\u00e9 dans le d\u00e9veloppement pharmaceutique, ce qui lui a permis d’acqu\u00e9rir une vaste exp\u00e9rience technique et scientifique.<\/p>

Avant de rejoindre Neuraxpharm, il a occup\u00e9 plusieurs postes de responsabilit\u00e9 dans le domaine du d\u00e9veloppement commercial, notamment dans l’octroi de licences chez Invent Farma et Hetero Europe, ainsi que dans l’obtention de licences et le d\u00e9veloppement commercial par le biais de partenariats strat\u00e9giques et de d\u00e9veloppements d’entreprise.<\/p>

Il a obtenu une licence en pharmacie de l’universit\u00e9 de Barcelone et un MBA de l’institut d’enseignement international ESADE.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

https:\/\/www.linkedin.com\/in\/mbarrero\/ Neuraxpharm Miguel Barrero Miguel Barrero Dur\u00e1n est Head of Business Development & Innovation et a rejoint Neuraxpharm en 2015 o\u00f9 il a cr\u00e9\u00e9 et d\u00e9velopp\u00e9 les d\u00e9partements du d\u00e9veloppement commercial et des licences, de la gestion des alliances et, r\u00e9cemment, du portefeuille de produits. Miguel dirige \u00e9galement le d\u00e9partement de propri\u00e9t\u00e9 intellectuelle. Il a […]<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":1998,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"elementor_header_footer","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-26742","page","type-page","status-publish","hentry"],"yoast_head":"\nMIGUEL BARRERO - Neuraxpharm Switzerland<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous\/comite-executif\/miguel-barrero-2\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MIGUEL BARRERO\" \/>\n<meta property=\"og:description\" content=\"https:\/\/www.linkedin.com\/in\/mbarrero\/ Neuraxpharm Miguel Barrero Miguel Barrero Dur\u00e1n est Head of Business Development & Innovation et a rejoint Neuraxpharm en 2015 o\u00f9 il a cr\u00e9\u00e9 et d\u00e9velopp\u00e9 les d\u00e9partements du d\u00e9veloppement commercial et des licences, de la gestion des alliances et, r\u00e9cemment, du portefeuille de produits. Miguel dirige \u00e9galement le d\u00e9partement de propri\u00e9t\u00e9 intellectuelle. Il a […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous\/comite-executif\/miguel-barrero-2\" \/>\n<meta property=\"og:site_name\" content=\"Neuraxpharm Switzerland\" \/>\n<meta property=\"article:modified_time\" content=\"2023-03-27T09:45:17+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.neuraxpharm.com\/ch-fr\/wp-content\/uploads\/sites\/16\/2023\/03\/m-barrero.jpg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture est.\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous\/comite-executif\/miguel-barrero-2\",\"url\":\"https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous\/comite-executif\/miguel-barrero-2\",\"name\":\"MIGUEL BARRERO - Neuraxpharm Switzerland\",\"isPartOf\":{\"@id\":\"https:\/\/www.neuraxpharm.com\/ch-fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous\/comite-executif\/miguel-barrero-2#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous\/comite-executif\/miguel-barrero-2#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.neuraxpharm.com\/ch-fr\/wp-content\/uploads\/sites\/16\/2023\/03\/m-barrero.jpg\",\"datePublished\":\"2023-01-30T13:53:57+00:00\",\"dateModified\":\"2023-03-27T09:45:17+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous\/comite-executif\/miguel-barrero-2#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous\/comite-executif\/miguel-barrero-2\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous\/comite-executif\/miguel-barrero-2#primaryimage\",\"url\":\"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/16\/2023\/03\/27093958\/m-barrero.jpg\",\"contentUrl\":\"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/16\/2023\/03\/27093958\/m-barrero.jpg\",\"width\":716,\"height\":700},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous\/comite-executif\/miguel-barrero-2#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"\u00c0 propos de nous\",\"item\":\"https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Comit\u00e9 Ex\u00e9cutif\",\"item\":\"https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous\/comite-executif\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"MIGUEL BARRERO\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.neuraxpharm.com\/ch-fr\/#website\",\"url\":\"https:\/\/www.neuraxpharm.com\/ch-fr\/\",\"name\":\"Neuraxpharm Switzerland\",\"description\":\"Ein europ\u00e4ischer Marktf\u00fchrer f\u00fcr CNS-Produkte\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.neuraxpharm.com\/ch-fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"MIGUEL BARRERO - Neuraxpharm Switzerland","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous\/comite-executif\/miguel-barrero-2","og_locale":"fr_FR","og_type":"article","og_title":"MIGUEL BARRERO","og_description":"https:\/\/www.linkedin.com\/in\/mbarrero\/ Neuraxpharm Miguel Barrero Miguel Barrero Dur\u00e1n est Head of Business Development & Innovation et a rejoint Neuraxpharm en 2015 o\u00f9 il a cr\u00e9\u00e9 et d\u00e9velopp\u00e9 les d\u00e9partements du d\u00e9veloppement commercial et des licences, de la gestion des alliances et, r\u00e9cemment, du portefeuille de produits. Miguel dirige \u00e9galement le d\u00e9partement de propri\u00e9t\u00e9 intellectuelle. Il a […]","og_url":"https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous\/comite-executif\/miguel-barrero-2","og_site_name":"Neuraxpharm Switzerland","article_modified_time":"2023-03-27T09:45:17+00:00","og_image":[{"url":"https:\/\/www.neuraxpharm.com\/ch-fr\/wp-content\/uploads\/sites\/16\/2023\/03\/m-barrero.jpg","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture est.":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous\/comite-executif\/miguel-barrero-2","url":"https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous\/comite-executif\/miguel-barrero-2","name":"MIGUEL BARRERO - Neuraxpharm Switzerland","isPartOf":{"@id":"https:\/\/www.neuraxpharm.com\/ch-fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous\/comite-executif\/miguel-barrero-2#primaryimage"},"image":{"@id":"https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous\/comite-executif\/miguel-barrero-2#primaryimage"},"thumbnailUrl":"https:\/\/www.neuraxpharm.com\/ch-fr\/wp-content\/uploads\/sites\/16\/2023\/03\/m-barrero.jpg","datePublished":"2023-01-30T13:53:57+00:00","dateModified":"2023-03-27T09:45:17+00:00","breadcrumb":{"@id":"https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous\/comite-executif\/miguel-barrero-2#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous\/comite-executif\/miguel-barrero-2"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous\/comite-executif\/miguel-barrero-2#primaryimage","url":"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/16\/2023\/03\/27093958\/m-barrero.jpg","contentUrl":"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/16\/2023\/03\/27093958\/m-barrero.jpg","width":716,"height":700},{"@type":"BreadcrumbList","@id":"https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous\/comite-executif\/miguel-barrero-2#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"\u00c0 propos de nous","item":"https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous"},{"@type":"ListItem","position":2,"name":"Comit\u00e9 Ex\u00e9cutif","item":"https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous\/comite-executif"},{"@type":"ListItem","position":3,"name":"MIGUEL BARRERO"}]},{"@type":"WebSite","@id":"https:\/\/www.neuraxpharm.com\/ch-fr\/#website","url":"https:\/\/www.neuraxpharm.com\/ch-fr\/","name":"Neuraxpharm Switzerland","description":"Ein europ\u00e4ischer Marktf\u00fchrer f\u00fcr CNS-Produkte","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.neuraxpharm.com\/ch-fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"}]}},"acf":[],"_links":{"self":[{"href":"https:\/\/www.neuraxpharm.com\/ch-fr\/wp-json\/wp\/v2\/pages\/26742","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.neuraxpharm.com\/ch-fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.neuraxpharm.com\/ch-fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.neuraxpharm.com\/ch-fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.neuraxpharm.com\/ch-fr\/wp-json\/wp\/v2\/comments?post=26742"}],"version-history":[{"count":13,"href":"https:\/\/www.neuraxpharm.com\/ch-fr\/wp-json\/wp\/v2\/pages\/26742\/revisions"}],"predecessor-version":[{"id":26882,"href":"https:\/\/www.neuraxpharm.com\/ch-fr\/wp-json\/wp\/v2\/pages\/26742\/revisions\/26882"}],"up":[{"embeddable":true,"href":"https:\/\/www.neuraxpharm.com\/ch-fr\/wp-json\/wp\/v2\/pages\/1998"}],"wp:attachment":[{"href":"https:\/\/www.neuraxpharm.com\/ch-fr\/wp-json\/wp\/v2\/media?parent=26742"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}